Revisions Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.09 USD +7.92% Intraday chart for Xilio Therapeutics, Inc. -5.22% +98.18%

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. XLO Stock
  4. Revisions Xilio Therapeutics, Inc.